Skip to search.
 TSX Down 0.13% TSX Ventures Up 0.28%

Abbott Laboratories (ABT)

-NYSE
39.30 Up 0.41(1.05%) May 27, 4:02PM EDT
Prev Close:38.89
Open:39.04
Bid:38.60 x 100
Ask:39.34 x 1000
1y Target Est:46.67
Beta:1.47696
Earnings Date:Jul 20 - Jul 25 (Est.)
Day's Range:38.92 - 39.40
52wk Range:36.00 - 51.74
Volume:12,339,372
Avg Vol (3m):8,922,580
Market Cap:57.74B
P/E (ttm):24.20
EPS (ttm):1.62
Div & Yield:1.04 (2.65%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTUp 1.05%57.74B

Key Statistics

Forward P/E (1 yr):15.91
P/S (ttm):2.80
Ex-Dividend Date:13-Apr-16

Analysts

Annual EPS Est (Dec-16) :2.21
Quarterly EPS Est (Jun-16) :0.53
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback